Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
June 21, 2021
Methods for the masses: multiplexed growth signaling analyses by mass spec
From the Paulovich Lab, Clinical Research Division, and colleagues
Taking aim: Mesothelin as a novel target for pediatric AML therapy
From the Meshinchi Lab, Clinical Research Division, and Cancer Consortium colleagues
New Scientific Publications
Each week, Fred Hutch librarians search PubMed and Web of Science to discover new papers published by Fred Hutch authors
Week of June 20, 2021
One patient’s fight against gastrointestinal stromal tumors
From the Pollack lab, Clinical Research Division
Adoptive transfer of engineered T cells prolongs survival in preclinical ovarian cancer
From the Greenberg lab, Clinical Research Division, and the Vaccine and Infectious Disease Division
Reprograming macrophages with nanoparticles
From the Stephan Lab, Clinical Research Division
Cells from baby and rheumatoid arthritis
From the Nelson lab, Clinical Research Division
Eliminating residual multiple myeloma with precision
From the Green Lab, Clinical Research Division
Colon cancer risk and senescence-associated colon microenvironment
From the Grady Lab, Clinical Research Division
Gene-modified cells in the brain
From the Kiem Lab, Clinical Research Division
Scientists learn how common virus reactivates after transplantation
New Science paper describes how antibody-producing B cells, not disease-fighting T cells, protect against reactivation of cytomegalovirus
“Exciting” but early results in trial of immunotherapy for myeloma
Cancer cells disappeared rapidly in patients with high-risk, treatment-resistant disease
Understanding the genetics of X chromosome inactivation
from the Bedalov lab, Clinical Research Division
Molecular mechanisms of late cancer relapse
from the Chapuis lab, Clinical Research Division
Revealing a new way that cancer can evade immunotherapy — and, maybe, how to stop it
How a new technology solved a mystery and honors one man’s legacy
Taking the shortcut to frontline treatment
From Dr. Schmitt and the Radich lab, Clinical Research Division
The prized fraction of Fanconi Anemia
from the Adair lab and the Kiem lab, Clinical Research Division
Taking the good out of viruses to cure immunodeficiencies by in vivo gene therapy
from the Kiem lab, Clinical Research Division
Esophageal adenocarcinoma: when DNA methylation informs the treatment
from the Grady lab, Clinical Research Division
The legacy of a pioneering transplant immunologist
‘So much to be learned’: Dr. John Hansen reflects on the lives he’s saved and the answers still to come
Personalized medicine for head and neck cancer
from the Mendez lab, Clinical Research Division, and Kemp lab, Human Biology Division